SymBiosis Hires Jahan Ali, PhD as Vice President of Business Development - read this article along with other careers information, tips and advice on BioSpace
MaaT Pharma becomes the first company developing microbiome-based drugs to be listed on the regulated market of Euronext Paris Capital increase of €31.5m and which could be increased to €36.2m